Science Explorer Back to mapMap

Most cited papers in Cholinesterase and Neurodegenerative Diseases

Cholinesterase and Neurodegenerative Diseases

What are the most cited papers in Cholinesterase and Neurodegenerative Diseases?

The most cited paper in Cholinesterase and Neurodegenerative Diseases is "A new and rapid colorimetric determination of acetylcholinesterase activity" (George L. Ellman, K. Diane Courtney, Valentino Andres et al., 1961), with 27,264 citations. Next come "The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics" (14,017) and "Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels" (12,959).

Showing 50 of 99 papers. Every paper with more than 1,253 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 A new and rapid colorimetric determination of acetylcholinesterase activity George L. Ellman, K. Diane Courtney, Valentino Andres et al. · Biochemical Pharmacology Jul 1961 27,264
2 The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics John Hardy, Dennis J. Selkoe · Science 19 Jul 2002 14,017
3 Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels Charles Beauchamp, Irwin Fridovich · Analytical Biochemistry Nov 1971 12,959
4 Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families Elizabeth H. Corder, Ann M. Saunders, Warren J. Strittmatter et al. · Science 13 Aug 1993 9,582
5 Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity Elisabetta Polazzi, Ilaria Mengoni, Marco Caprini et al. · Neurosignals Open access 9 May 2012 9,018
6 Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Reisa Anne Sperling et al. · Alzheimer s & Dementia Open access 22 Apr 2011 7,286
7 International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels William A. Catterall, K. George Chandy, David E. Clapham et al. · Pharmacological Reviews Dec 2003 7,147
8 Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis Daniel R. Rosen et al. · Nature Mar 1993 7,116
9 Alzheimer's Disease: Genes, Proteins, and Therapy Dennis J. Selkoe · Physiological Reviews Review Apr 2001 6,113
10 The Cholinergic Hypothesis of Geriatric Memory Dysfunction Raymond T. Bartus, Reginald L. Dean, Bernard Beer et al. · Science 30 Jul 1982 5,576
11 Alzheimer's Disease Henry W. Querfurth, Frank M. LaFerla · New England Journal of Medicine 27 Jan 2010 4,526
12 Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo Dominic M. Walsh, Igor V. Klyubin, Julia V. Fadeeva et al. · Nature Apr 2002 4,323
13 β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE Robert J. Vassar et al. · Science Open access 22 Oct 1999 3,870
14 Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain PJ Whitehouse, DL Price, R. G. Struble et al. · Science 5 Mar 1982 3,640
15 Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy Chia‐Chen Liu, Takahisa Kanekiyo, Huaxi Xu et al. · Nature Reviews Neurology ReviewOpen access 8 Jan 2013 3,567
16 Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins Mary P. Lambert, Avlin K. Barlow, Brett A. Chromy et al. · Proceedings of the National Academy of Sciences Open access 26 May 1998 3,539
17 Alzheimer Disease: An Update on Pathobiology and Treatment Strategies Justin M. Long, David M. Holtzman · Cell Open access 26 Sep 2019 3,342
18 ProTox-II: a webserver for the prediction of toxicity of chemicals Priyanka Banerjee, Andreas Philipp Eckert, Anna K. Schrey et al. · Nucleic Acids Research Open access 26 Apr 2018 3,237
19 Carbonic anhydrases: novel therapeutic applications for inhibitors and activators Claudiu Trandafir Supuran · Nature Reviews Drug Discovery Review 2 Jan 2008 3,205
20 The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease Jeff Sevigny et al. · Nature 30 Aug 2016 3,131
21 Alzheimer's disease Kaj Blennow, Mony J. de Leon, Henrik Zetterberg · The Lancet Jul 2006 3,113
22 Pathways towards and away from Alzheimer's disease Mark P. Mattson · Nature Open access 4 Aug 2004 3,075
23 Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation Joseph T. Coyle, Donald L. Price, Mahlon R. DeLong · Science 11 Mar 1983 3,071
24 Comprehensive Review on Alzheimer’s Disease: Causes and Treatment Zeinab Breijyeh, Rafik Karaman · Molecules Open access 8 Dec 2020 2,780
25 The molecular pathology of Alzheimer's disease Dennis J. Selkoe · Neuron Apr 1991 2,750
26 Atomic Structure of Acetylcholinesterase from Torpedo californica : A Prototypic Acetylcholine-Binding Protein Joel L. Sussman, Michal Harel, Felix Frolow et al. · Science 23 Aug 1991 2,723
27 Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung David W. Cushman, Hong Son Cheung · Biochemical Pharmacology Jul 1971 2,638
28 Acetylcholinesterase Inhibitors: Pharmacology and Toxicology Mirjana B. Čolović, Danijela Z. Krstic, Tamara D. Lazarević Pašti et al. · Current Neuropharmacology Open access Apr 2013 2,613
29 Alzheimer's disease Chris Lane, John Hardy, Jonathan M. Schott · European Journal of Neurology Open access 5 Sep 2017 2,612
30 Alzheimer disease David S. Knopman, Hélène Amieva, Ronald Carl Petersen et al. · Nature Reviews Disease Primers ReviewOpen access 13 May 2021 2,543
31 Pathological roles of MAPK signaling pathways in human diseases Eun-Kyung Kim, Eui‐Ju Choi · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease Open access 15 Jan 2010 2,527
32 Oxidative Stress Hypothesis in Alzheimer's Disease William R. Markesbery · Free Radical Biology and Medicine 1997 2,390
33 Central cholinergic pathways in the rat: An overview based on an alternative nomenclature (Ch1–Ch6) M.‐Marsel Mesulam, Elliott Jay Mufson, Bruce H. Wainer et al. · Neuroscience Dec 1983 2,341
34 Alzheimer's Disease: Cell-Specific Pathology Isolates the Hippocampal Formation Bradley T. Hyman, Gary W. Van Hoesen, António R. Damásio et al. · Science 14 Sep 1984 2,286
35 admetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties Feixiong Cheng, Weihua Li, Yadi Zhou et al. · Journal of Chemical Information and Modeling 23 Oct 2012 2,269
36 The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics Eric H. Karran, Marc H. Mercken, Bart De Strooper · Nature Reviews Drug Discovery Review 19 Aug 2011 2,240
37 Amyloid-β and Tau George S. Bloom · JAMA Neurology Open access 3 Feb 2014 2,235
38 Tau-mediated neurodegeneration in Alzheimer's disease and related disorders Carlo Ballatore, Virginia M.‐Y. Lee, John Q. Trojanowski · Nature reviews. Neuroscience Review 8 Aug 2007 2,217
39 Oxidative stress and the amyloid beta peptide in Alzheimer’s disease Clémence Cheignon, Mireia Tomas, Dominique Bonnefont‐Rousselot et al. · Redox Biology Open access 19 Oct 2017 2,206
40 The cholinergic hypothesis of Alzheimer's disease: a review of progress Paul T. Francis, Alan M. Palmer, Mike Snape et al. · Journal of Neurology Neurosurgery & Psychiatry Open access Feb 1999 2,197
41 Amyloid Precursor Protein Processing and Alzheimer's Disease Richard O’Brien, Philip C. Wong · Annual Review of Neuroscience ReviewOpen access Mar 2011 2,108
42 Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene Evgeny Ivanovich Rogaev et al. · Nature Aug 1995 2,073
43 Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Elaine K. Perry, B. E. Tomlinson, G. Blessed et al. · BMJ Open access 25 Nov 1978 2,055
44 Amyloid beta: structure, biology and structure-based therapeutic development Guo-fang Chen, Ting-Hai Xu, Yan Yan et al. · Acta Pharmacologica Sinica Open access 17 Jul 2017 2,015
45 The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes Iryna Benilova, Eric H. Karran, Bart De Strooper · Nature Neuroscience 29 Jan 2012 2,009
46 Intracellular amyloid-β in Alzheimer's disease Frank M. LaFerla, Kim N. Green, Salvatore Oddo · Nature reviews. Neuroscience Review 6 Jun 2007 1,959
47 Aβ Oligomers – a decade of discovery Dominic M. Walsh, Dennis J. Selkoe · Journal of Neurochemistry Open access 4 Jan 2007 1,947
48 Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease Elizabeth H. Corder, Ann M. Saunders, NEIL J. RISCH et al. · Nature Genetics Jun 1994 1,941
49 The Amyloid-β Pathway in Alzheimer’s Disease Harald Juergen Hampel, John Hardy, Kaj Blennow et al. · Molecular Psychiatry Open access 29 Aug 2021 1,929
50 Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model Erik D. Roberson, Kimberly A. Scearce-Levie, Jorge J. Palop et al. · Science 3 May 2007 1,918

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.